Copyright © 2005, European Society of Cardiology
L-Arginine administration recovers sarcoplasmic reticulum function in ischemic reperfused hearts by preventing calpain activation
Institute of Cardiovascular Sciences, St. Boniface General Hospital Research Centre, 351 Tache Avenue, Winnipeg, Manitoba, Canada R2H 2A6
* Corresponding author. Tel.: +1 204 237 2691; fax: +1 204 233 6723. Email address: tnetticadan{at}sbrc.ca
Objective: Earlier studies have shown that impaired cardiac contractility in ischemia reperfusion (IR) is associated with alterations in sarcoplasmic reticulum (SR) function. Impaired release of nitric oxide (NO) has been reported during IR, while administration of NO donors, such as L-arginine (LA), has been shown to improve cardiac performance in IR hearts. We therefore investigated the mechanisms underlying the recovery of contractile function in IR hearts treated with LA.
Methods: Isolated rat hearts subjected to 30 min of global ischemia were reperfused for 60 min. The effects of LA on cardiac performance, SR function and its regulation were examined.
Results: IR-induced impairment in cardiac performance was associated with a reduction in SR function and its regulation. IR caused an increase in calpain activity and a decrease in the sarcolemmal and SR nitric oxide synthase (NOS) isoform protein content as well as cytosolic NO levels. Administration of LA prevented contractile dysfunction in IR hearts, which was associated with a recovery of SR function and SR regulation by protein phosphorylation. This was consistent with a recovery in protein levels of major SR Ca2+-cycling and Ca2+-regulatory proteins. LA treatment attenuated an increase in calpain activity, possibly by nitrosylation of calpain, and increased cytosolic NO levels and SR NOS protein content in IR hearts.
Discussion: These results suggest that LA administration improved cardiac contractility by preventing alterations in SR Ca2+ handling and calpain activation in IR hearts.
Time for primary review 25 days
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  R. Ward, N. Souder, D. Stahl, F. Hunter, R. Probe, C. Chaput, and E. Childs The Role of Nitric Oxide Synthase and Heme Oxygenase in the Protective Effect of Hypothermia in Ischemia-Reperfusion Injury J. Bone Joint Surg. Am., November 1, 2009; 91(11): 2637 - 2645. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Yu, Z.-H. Wang, and H.-T. Yang Calcium/calmodulin-dependent protein kinase II mediates cardioprotection of intermittent hypoxia against ischemic-reperfusion-induced cardiac dysfunction Am J Physiol Heart Circ Physiol, August 1, 2009; 297(2): H735 - H742. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. B. Singh, V. Elimban, and N. S. Dhalla Differences in ischemia-reperfusion-induced endothelial changes in hearts perfused at constant flow and constant pressure J Appl Physiol, December 1, 2008; 105(6): 1779 - 1787. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. K. Mani, H. Shiraishi, S. Balasubramanian, K. Yamane, M. Chellaiah, G. Cooper, N. Banik, M. R. Zile, and D. Kuppuswamy In vivo administration of calpeptin attenuates calpain activation and cardiomyocyte loss in pressure-overloaded feline myocardium Am J Physiol Heart Circ Physiol, July 1, 2008; 295(1): H314 - H326. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Loyer, A. M. Gomez, P. Milliez, M. Fernandez-Velasco, P. Vangheluwe, L. Vinet, D. Charue, E. Vaudin, W. Zhang, Y. Sainte-Marie, et al. Cardiomyocyte Overexpression of Neuronal Nitric Oxide Synthase Delays Transition Toward Heart Failure in Response to Pressure Overload by Preserving Calcium Cycling Circulation, June 24, 2008; 117(25): 3187 - 3198. [Abstract] [Full Text] [PDF]
|
|